Clinical Trials Browser

Phase 2 × Colonic Neoplasms × liposomal doxorubicin × Clear all

NCT01464593 2022-10-13

ABLATE

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Liver Neoplasms